| 1 |
Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins
Jeffrey L. Rossio, M. T. Esser, K. Suryanarayana et al. · Journal of Virology
Open access |
Oct 1998 |
420 |
| 2 |
Guidance on Good Cell Culture Practice
Sandra Coecke, Michael Balls, Gerard Bowe et al. · Alternatives to Laboratory Animals
|
Jun 2005 |
365 |
| 3 |
Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease
Edward G. D. Tuddenham, R. S. Lane, Frances Rotblat et al. · British Journal of Haematology
|
Oct 1982 |
180 |
| 4 |
NON-A, NON-B HEPATITIS FROM INTRAVENOUS IMMUNOGLOBULIN
R. S. Lane · The Lancet
|
Oct 1983 |
112 |
| 5 |
Virus inactivation by high intensity broad spectrum pulsed light
Peter L. Roberts, Andrew G. Hope · Journal of Virological Methods
|
19 May 2003 |
111 |
| 6 |
Production of human albumin solution: a continually developing colloid
Paul Matejtschuk, C. H. Dash, E. Gascoigne · British Journal of Anaesthesia
Open access |
Dec 2000 |
102 |
| 7 |
Characterization of flow intensity in continuous centrifuges for the development of laboratory mimics
M. Boychyn, Sung-Sam Yim, P. Ayazi Shamlou et al. · Chemical Engineering Science
|
Aug 2001 |
93 |
| 8 |
Triazine-dye affinity chromatography
Tony Atkinson, Peter Hammond, ROY D. HARTWELL et al. · Biochemical Society Transactions
|
Aug 1981 |
90 |
| 9 |
Performance prediction of industrial centrifuges using scale-down models
M. Boychyn, Sung-Sam Yim, Mark Bulmer et al. · Bioprocess and Biosystems Engineering
|
18 Oct 2003 |
85 |
| 10 |
A review on biocide reduced susceptibility due to plasmid‐borne antiseptic‐resistant genes—special notes on pharmaceutical environmental isolates
Rajendran Vijayakumar, Tim Sandle · Journal of Applied Microbiology
|
2 Oct 2018 |
77 |
| 11 |
Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii — A first report from the Kingdom of Saudi Arabia
Rajendran Vijayakumar, Tim Sandle, Mohammad Saleh Al-Aboody et al. · Journal of Infection and Public Health
Open access |
12 Jun 2018 |
71 |
| 12 |
Clearance of Rh D-positive red cells with monoclonal anti-D
Amanda R Thomson, Miguel Alejandro Saquimux Contreras, P. Teesdale et al. · The Lancet
|
Nov 1990 |
68 |
| 13 |
Production and Therapeutic Use of a Factor XI Concentrate from Plasma
Paula H. B. Bolton‐Maggs, Richard T. Wensley, PB Kernoff et al. · Thrombosis and Haemostasis
|
1992 |
67 |
| 14 |
Graphene oxide incorporated collagen–fibrin biofilm as a wound dressing material
R. Deepachitra, V. Ramnath, Thotapalli Parvathaleswara Sastry · RSC Advances
|
2014 |
66 |
| 15 |
Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin
Patrick Garland, Matthew J Morton, William Haskins et al. · Brain Communications
Open access |
2020 |
63 |
| 16 |
Fabrication of collagen scaffolds impregnated with sago starch capped silver nanoparticles suitable for biomedical applications and their physicochemical studies
Abhishek Mandal, Abhishek Mandal, Santhanam Sekar et al. · Physical Chemistry Chemical Physics
|
2014 |
57 |
| 17 |
Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII
Peter L. Roberts · Biologicals
|
4 Aug 2008 |
56 |
| 18 |
Synthesis, characterization and evaluation of collagen scaffolds crosslinked with aminosilane functionalized silver nanoparticles: in vitro and in vivo studies
Abhishek Mandal, Santhanam Sekar, Natarajan Chandrasekaran et al. · Journal of Materials Chemistry B
|
2015 |
52 |
| 19 |
Cell-surface markers on haemopoietic precursors. Reagents for the isolation and analysis of progenitor cell subpopulations
Suzanne M. Watt, David J. Gilmore, John M. Davis et al. · Molecular and Cellular Probes
|
Dec 1987 |
52 |
| 20 |
Laboratory scaledown of protein purification processes involving fractional precipitation and centrifugal recovery
M. Boychyn, W. M. Doyle, Mark Bulmer et al. · Biotechnology and Bioengineering
|
5 Jul 2000 |
51 |
| 21 |
Isolation of monocytes from human peripheral blood using immuno‐affinity expanded‐bed adsorption
L. B. Ujam, Robert H. Clemmitt, Susan A. Clarke et al. · Biotechnology and Bioengineering
|
20 Jun 2003 |
45 |
| 22 |
Vibrational spectroscopic investigation on interaction of sago starch capped silver nanoparticles with collagen: a comparative physicochemical study using FT-IR and FT-Raman techniques
Abhishek Mandal, Santhanam Sekar, Natarajan Chandrasekaran et al. · RSC Advances
|
2015 |
45 |
| 23 |
Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers
Jean Goodrick, Belinda M. Kumpel, DH Pamphilon et al. · Clinical & Experimental Immunology
Open access |
Oct 1994 |
44 |
| 24 |
Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
Nathan Roth, Herbert O. Dichtelmüller, Fabrizio Fabbrizzi et al. · Transfusion
Open access |
19 Aug 2020 |
43 |
| 25 |
Virus inactivation by protein denaturants used in affinity chromatography
Peter L. Roberts, David Hugh Lloyd · Biologicals
|
25 May 2007 |
42 |
| 26 |
Effects of Handling and Storage of Blood on the Stability of Hepatitis C Virus RNA: Implications for NAT Testing in Transfusion Practice
Paul R. Grant, Alan D. Kitchen, Jeffrey A.J. Barbara et al. · Vox Sanguinis
|
Apr 2000 |
41 |
| 27 |
Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronate
Gavin M. Spence, Stephen Phillips, Charlie R. Campion et al. · Journal of Bone and Joint Surgery - British Volume
Open access |
30 Nov 2008 |
41 |
| 28 |
Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography
Peter A. Feldman, P I Bradbury, John D. Williams et al. · Blood Coagulation & Fibrinolysis
|
Dec 1994 |
41 |
| 29 |
Scale‐down of continuous filtration for rapid bioprocess design: Recovery and dewatering of protein precipitate suspensions
Tommy Sean Reynolds, M. Boychyn, T. Sanderson et al. · Biotechnology and Bioengineering
|
4 Jun 2003 |
39 |
| 30 |
Resistance of Vaccinia Virus to Inactivation by Solvent/Detergent Treatment of Blood Products
Peter L. Roberts · Biologicals
|
Mar 2000 |
39 |
| 31 |
Activation of a procollagenase by low-molecular-weight angiogenesis factor
Jacqueline B. Weiss, Christopher R. Hill, R. J. Davis et al. · Bioscience Reports
|
Feb 1983 |
38 |
| 32 |
‘Gimme shelter’
Finola Kerrigan, Gretchen Larsen, Sorcha Hanratty et al. · Marketing Theory
Open access |
25 Feb 2014 |
36 |
| 33 |
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use
Mark B. Pepys, J. Ruth Gallimore, Joanne Lloyd et al. · Journal of Immunological Methods
Open access |
31 Jul 2012 |
36 |
| 34 |
Virus Safety of Plasma Products
Paula Roberts · Reviews in Medical Virology
|
Mar 1996 |
35 |
| 35 |
Severely Heated Therapeutic Factor VIII Concentrate of High Specific Activity
L. Winkelmana, N. E. Owena, David R. Evans et al. · Vox Sanguinis
|
Sep 1989 |
35 |
| 36 |
Liquid Flow and Mixing in Concentric Tube Air-Lift Reactors
José C. Merchuk, Narendra Ladwa, Angus Cameron et al. · Journal of Chemical Technology & Biotechnology
|
Jun 1996 |
33 |
| 37 |
Neurofilament light predicts neurological outcome after subarachnoid haemorrhage
Patrick Garland, Matt Morton, Ardalan H Zolnourian et al. · Brain
Open access |
22 Dec 2020 |
32 |
| 38 |
Efficacy, safety and pharmacokinetics of a new high‐purity factor X concentrate in subjects with hereditary factor X deficiency
Steve K. Austin, Kaan Kavaklı, M. Norton et al. · Haemophilia
Open access |
8 Mar 2016 |
31 |
| 39 |
In vitro fungicidal activity of biocides against pharmaceutical environmental fungal isolates
Tim Sandle, Rajendran Vijayakumar, Mohammed Saleh Al Aboody et al. · Journal of Applied Microbiology
|
23 Aug 2014 |
31 |
| 40 |
Experience of a new high‐purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery
Miguel Antonio Escobar, G. Auerswald, Steve K. Austin et al. · Haemophilia
|
24 May 2016 |
29 |
| 41 |
Fingerprinting of glycans as their 2‐aminoacridone derivatives by capillary electrophoresis and laserinduced fluorescence
Gary Harland, George N. Okafo, Paul Matejtschuk et al. · Electrophoresis
|
1996 |
29 |
| 42 |
Removal and Inactivation of Enveloped and Non‐Enveloped Viruses during the Purification of a High‐Purity Factor IX by Metal Chelate Affinity Chromatography
Peter L. Roberts, Chris P. Walker, Peter A. Feldman · Vox Sanguinis
|
Jun 1994 |
26 |
| 43 |
Virus elimination during the purification of monoclonal antibodies by column chromatography and additional steps
Peter L. Roberts · Biotechnology Progress
|
2 Sep 2014 |
24 |
| 44 |
Risk factors for the early acquisition of human herpesvirus 6 and human herpesvirus 7 infections in children
Bruce Perrin Lanphear, Caroline Breese Hall, Jodi B. Black et al. · The Pediatric Infectious Disease Journal
|
Sep 1998 |
24 |
| 45 |
Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita
U. Tayal, Janet Burton, C. H. Dash et al. · Clinical Immunology
|
11 Oct 2008 |
24 |
| 46 |
Comparison of the Inactivation of Canine and Bovine Parvovirus by Freeze-drying and Dry-heat Treatment in Two High Purity Factor VIII Concentrates
Peter L. Roberts, Helena Hart · Biologicals
|
Sep 2000 |
23 |
| 47 |
Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing
F LANAGAN, S NAPE · Transfusion Medicine
|
Mar 1998 |
23 |
| 48 |
Virological safety of the purified factor IX concentrate, Replenine
Peter B. Roberts · Haemophilia
|
1995 |
23 |
| 49 |
Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
Tim Sandle, Madhu Raju Saghee · Journal of Commercial Biotechnology
|
2 Aug 2011 |
23 |
| 50 |
A cross‐over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate
D P Thomas, K. K. Hampton, H. Dasani et al. · British Journal of Haematology
|
Aug 1994 |
23 |